申请人:The Du Pont Merck Pharmaceutical Company
公开号:US05488110A1
公开(公告)日:1996-01-30
This invention relates to bis-naphthalimides, including 2,2'-[1,2-ethanediylbis(methylimino-2,1-ethanediyl)]-bis[5-nitro-1H-benz[d e]isoquinoline-1,3(2H)-dione], 2-[2-[N-methyl-N-[2-[[2-(5-nitro-1,3-dioxo-1H-benz[de]isoquinoline-2(3H)-y l)ethyl]amino]ethyl]amino]ethyl]-5-nitro-1H-benz[de]isoquinoline-1,3(2H)-di one, 2,2'-[1,2-ethanediylbis(imino-2,1-ethanediyl)]-bis[5-nitro-1H-benz[de]isoq uinoline-1,3(2H)-dione], pharmaceutical compositions containing them, and methods of using them to treat solid tumor carcinomas in mammals.
这项发明涉及双萘酰亚胺,包括2,2'-[1,2-乙二基双(甲基亚胺-2,1-乙二基)]-双[5-硝基-1H-苯并[d e]异喹啉-1,3(2H)-二酮],2-[2-[N-甲基-N-[2-[[2-(5-硝基-1,3-二氧-1H-苯[de]异喹啉-2(3H)-基)乙基]氨基]乙基]氨基]乙基]-5-硝基-1H-苯[de]异喹啉-1,3(2H)-二酮,2,2'-[1,2-乙二基亚胺-2,1-乙二基]-双[5-硝基-1H-苯[de]异喹啉-1,3(2H)-二酮],含有它们的药物组合物,以及使用它们治疗哺乳动物实体肿瘤癌症的方法。